(±)-半富马酸比索洛尔 ≥98%
促销价¥{{model.attbuying.price}}
市场价¥0.00
累计销量0 累计评价0 人评论
-
{{item.title}}
| 包装规格: | 1g in glass bottle |
| 产品简介: | 一种β1肾上腺素受体阻断剂。 |
| 溶解性: | 溶于水(20mg/mL 超声),溶于DMSO(≥50mg/mL) |
| 储备液保存: | -80°C, 6 months -20°C, 1 month (sealed storage, away from moisture) |
| 体内实验: | 1、请依序添加每种溶剂: PBS Solubility: 100 mg/mL (260.77 mM); 澄清溶液; 超声助溶 <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
| 靶点: | Beta-1 adrenergic receptor |
| 体外研究: | Bisoprolol hemifumarate(2 μM, 1 h) protects myocardial cells (H9c2) from ischemia/reperfusion (I/R) injury. Bisoprolol hemifumarate(2 μM, 1 h)reduces the H/R-induced ROS production and apoptosis in H9c2 cells. Bisoprolol hemifumarate(2 μM, 1 h) increases AKT and GSK3β phosphorylation in H9c2 cells. Bisoprolol hemifumarate(100 μM, 24 h) reverses Epinephrine-inhibited emigration in cholesterol-loaded DCs (dendritic cell) through increasing in β-arrestin 2, CCR7 and PI3K phosphorylation. |
| 体内研究: | Bisoprolol hemifumarate (oral administration, 5 mg/kg, for 1 week) increases left ventricular ejection fraction (LVEF) and decreases the heart rate value. Bisoprolol hemifumarate (oral gavage, 8 mg/kg, daily for four weeks) shows protective effects against Cadmium-induced myocardial toxicity in rats. Bisoprolol hemifumarate (oral gavage, 1 mg/kg, daily for 6 weeks) reversessmall conductance calcium-activated potassium channel (SK) remodeling in a volume-overload rat model. |
| 保存条件: | -20℃ |
| 注意事项: | 1、为了您的安全和健康,请穿实验服并戴一次性手套操作。 2、以上信息仅做参考交流之用。 |
-
蜀牛玻璃三角瓶
¥85.00 销量:16
-
15mL锥底离心管,袋装灭菌,橙色盖
¥636.00 销量:12
-
UFC5030BK 超滤管[0.5ml 30KD]
¥52.00 销量:10
-
UFC5010BK 超滤管[0.5ml 10KD]
¥52.00 销量:10
-
20×TBST缓冲液
¥130.00 销量:10
-
10mL移液管,易撕型全塑包装
¥456.00 销量:10
-
¥158.00
通用型 DNA 纯化回收试剂盒 -
¥158.00
质粒快速小提试剂盒 -
¥828.00
100mm TC细胞培养皿,袋装灭菌

